A Whole-Genome Sequencing-Based Approach for the Characterization of

Klebsiella pneumoniae carbapenemases whole-genome sequencing β-lactam/β-lactamases inhibitors

Journal

Microorganisms
ISSN: 2076-2607
Titre abrégé: Microorganisms
Pays: Switzerland
ID NLM: 101625893

Informations de publication

Date de publication:
20 Sep 2023
Historique:
received: 07 08 2023
revised: 16 09 2023
accepted: 18 09 2023
medline: 28 9 2023
pubmed: 28 9 2023
entrez: 28 9 2023
Statut: epublish

Résumé

Whole-genome sequencing (WGS) provides important information for the characterization, surveillance, and monitoring of antimicrobial resistance (AMR) determinants, particularly in cases of multi- and extensively drug-resistant microorganisms. We reported the results of a WGS analysis carried out on carbapenemases-producing Clinical, phenotypic, and genotypic data were collected for the AMR surveillance screening program of the University Hospital of Sassari (Italy) during 2020-2021. Genomic DNA was sequenced using the Illumina Nova Seq 6000 platform. Final assemblies were manually curated and carefully verified for the detection of antimicrobial resistance genes, porin mutations, and virulence factors. A phylogenetic analysis was performed using the maximum likelihood method. All 17 strains analyzed belonged to ST512, and most of them carried the WGS characterization revealed the presence of several antibiotic resistance determinants and porin mutations in highly resistant

Sections du résumé

BACKGROUND BACKGROUND
Whole-genome sequencing (WGS) provides important information for the characterization, surveillance, and monitoring of antimicrobial resistance (AMR) determinants, particularly in cases of multi- and extensively drug-resistant microorganisms. We reported the results of a WGS analysis carried out on carbapenemases-producing
METHODS METHODS
Clinical, phenotypic, and genotypic data were collected for the AMR surveillance screening program of the University Hospital of Sassari (Italy) during 2020-2021. Genomic DNA was sequenced using the Illumina Nova Seq 6000 platform. Final assemblies were manually curated and carefully verified for the detection of antimicrobial resistance genes, porin mutations, and virulence factors. A phylogenetic analysis was performed using the maximum likelihood method.
RESULTS RESULTS
All 17 strains analyzed belonged to ST512, and most of them carried the
CONCLUSION CONCLUSIONS
WGS characterization revealed the presence of several antibiotic resistance determinants and porin mutations in highly resistant

Identifiants

pubmed: 37764198
pii: microorganisms11092354
doi: 10.3390/microorganisms11092354
pmc: PMC10535212
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

Microbiol Spectr. 2022 Aug 31;10(4):e0100022
pubmed: 35863018
Front Cell Infect Microbiol. 2018 Jan 22;8:4
pubmed: 29404282
Microb Genom. 2022 Mar;8(3):
pubmed: 35311639
Antimicrob Agents Chemother. 2011 Oct;55(10):4896-9
pubmed: 21768505
Genome Res. 2018 Sep;28(9):1395-1404
pubmed: 30049790
Clin Microbiol Infect. 2023 May;29(5):654.e1-654.e4
pubmed: 36716999
JAC Antimicrob Resist. 2022 Sep 13;4(5):dlac089
pubmed: 36111208
Open Forum Infect Dis. 2021 Mar 20;8(6):ofab141
pubmed: 34189161
BMC Bioinformatics. 2010 Dec 10;11:595
pubmed: 21143983
Open Forum Infect Dis. 2017 Jul 01;4(3):ofx101
pubmed: 28685153
Lancet. 2022 Feb 12;399(10325):629-655
pubmed: 35065702
Bioinformatics. 2015 Nov 15;31(22):3691-3
pubmed: 26198102
BMC Microbiol. 2021 Aug 19;21(1):230
pubmed: 34412588
Front Microbiol. 2019 Aug 20;10:1823
pubmed: 31481937
Lancet Microbe. 2023 Mar;4(3):e179-e191
pubmed: 36736332
Microb Genom. 2018 Dec;4(12):
pubmed: 30465646
Antimicrob Agents Chemother. 2022 May 17;66(5):e0019122
pubmed: 35416711
Clin Microbiol Rev. 2015 Jul;28(3):565-91
pubmed: 25926236
Bioinformatics. 2018 Sep 1;34(17):i884-i890
pubmed: 30423086
J Antimicrob Chemother. 2021 Jan 1;76(1):101-109
pubmed: 33009809
Int J Environ Res Public Health. 2022 Feb 24;19(5):
pubmed: 35270321
JAC Antimicrob Resist. 2023 Mar 23;5(2):dlad022
pubmed: 36968951
Front Cell Infect Microbiol. 2022 Sep 08;12:988236
pubmed: 36159637
Clin Infect Dis. 2016 Dec 15;63(12):1615-1618
pubmed: 27624958
Nucleic Acids Res. 2021 Jul 2;49(W1):W293-W296
pubmed: 33885785
Genome Biol. 2014;15(11):524
pubmed: 25410596
Antimicrob Agents Chemother. 2020 Mar 24;64(4):
pubmed: 31964792
J Antimicrob Chemother. 2016 Dec;71(12):3386-3391
pubmed: 27585968
Antibiotics (Basel). 2022 Dec 21;12(1):
pubmed: 36671211
J Hosp Infect. 2018 Aug;99(4):413-418
pubmed: 29621600
Antimicrob Agents Chemother. 2001 Apr;45(4):1151-61
pubmed: 11257029
J Antimicrob Chemother. 2018 Jun 1;73(6):1525-1529
pubmed: 29566151
Eur J Clin Microbiol Infect Dis. 2023 Mar;42(3):229-254
pubmed: 36680641
Antimicrob Resist Infect Control. 2020 Jan 17;9(1):18
pubmed: 31988746
J Comput Biol. 2012 May;19(5):455-77
pubmed: 22506599
Microorganisms. 2023 Feb 09;11(2):
pubmed: 36838402
Antimicrob Agents Chemother. 2017 Sep 22;61(10):
pubmed: 28739787
Microb Genom. 2020 Oct;6(10):
pubmed: 32969786
Mol Biol Evol. 2015 Jan;32(1):268-74
pubmed: 25371430
Microb Genom. 2018 Aug;4(8):
pubmed: 30052170
Antimicrob Agents Chemother. 2017 Feb 23;61(3):
pubmed: 28031201
Antimicrob Agents Chemother. 2012 Jan;56(1):559-62
pubmed: 22083465
mSphere. 2021 Jan 13;6(1):
pubmed: 33441403
Eur J Clin Microbiol Infect Dis. 2022 Mar;41(3):495-500
pubmed: 34988712
Curr Opin Microbiol. 2018 Oct;45:131-139
pubmed: 29723841
Int J Antimicrob Agents. 2016 Feb;47(2):151-4
pubmed: 26795023
Lancet Infect Dis. 2018 Mar;18(3):e99-e106
pubmed: 29102325
Microorganisms. 2021 Jun 17;9(6):
pubmed: 34204279
Antimicrob Agents Chemother. 2015 Sep;59(9):5793-7
pubmed: 26169413
Antimicrob Agents Chemother. 2022 Sep 20;66(9):e0044722
pubmed: 35980232
Nat Methods. 2017 Jun;14(6):587-589
pubmed: 28481363
Antimicrob Agents Chemother. 2008 Apr;52(4):1257-63
pubmed: 18227185
Bioinformatics. 2014 Jul 15;30(14):2068-9
pubmed: 24642063
Antimicrob Agents Chemother. 2021 Aug 17;65(9):e0089021
pubmed: 34228551
Clin Infect Dis. 2021 May 4;72(9):1657-1659
pubmed: 32544232
J Med Microbiol. 2018 Jul;67(7):957-964
pubmed: 29873627

Auteurs

Arcadia Del Rio (A)

Department of Biomedical Science, University of Sassari, 07100 Sassari, Italy.

Valeria Fox (V)

Department of Oncology and Hemato-Oncology, University of Milan, 20122 Milan, Italy.

Narcisa Muresu (N)

Department of Humanities and Social Sciences, University of Sassari, 07100 Sassari, Italy.

Illari Sechi (I)

Department of Medicine, Surgery, and Pharmacy, University of Sassari, 07100 Sassari, Italy.

Andrea Cossu (A)

Department of Medicine, Surgery, and Pharmacy, University of Sassari, 07100 Sassari, Italy.

Alessandra Palmieri (A)

Department of Medicine, Surgery, and Pharmacy, University of Sassari, 07100 Sassari, Italy.

Rossana Scutari (R)

Department of Oncology and Hemato-Oncology, University of Milan, 20122 Milan, Italy.

Claudia Alteri (C)

Department of Oncology and Hemato-Oncology, University of Milan, 20122 Milan, Italy.

Giovanni Sotgiu (G)

Clinical Epidemiology and Medical Statistics Unit, Department of Medical, Surgical and Experimental Medicine, University of Sassari, 07100 Sassari, Italy.

Paolo Castiglia (P)

Department of Medicine, Surgery, and Pharmacy, University of Sassari, 07100 Sassari, Italy.

Andrea Piana (A)

Department of Medicine, Surgery, and Pharmacy, University of Sassari, 07100 Sassari, Italy.

Classifications MeSH